Fujifilm Photography Company Now Produces COVID-19 Drug Too, Claimed Effective By Chinese Health Experts
Dhir Acharya
Fujifilm's coronavirus drug Avigan was complimented by Chinese health experts for its effectiveness in curing COVID-19 patients.
- This Man's Super-Antibody Can Be Diluted 10,000 Times But Still Works Against COVID-19
- These Indian Cities Are Under Lockdown Again In 2021
- India To Review Covishield Vaccine After Report Of Blood Clots Following Vaccination
For decades, Fujifilm has been known as a photography corporation, but the company itself has recognized its future in the healthcare area. On Wednesday, the Chinese government said that Avigan, a new flu drug from Toyama Chemical – a Fujifilm’s branch, proved a success in curing COVID-19 in testing. Shortly after the announcement, the company’s stock price went up by 15 percent.
Over the past 86 years, it’s been undeniable that Fujifilm is always willing to change. Founded in 1934, from a filmmaker, the company went through several turns, including film production, photocopy equipment, cameras, and now medical supplies.
Currently, healthcare accounts for 20 percent of Fujifilm’s total revenue of Rs 170.6 crore. Furthermore, the company is pursuing a 5-year plan to double its revenue in the healthcare sector, making it a new major part apart from stationary.
In 2008, Fujifilm starts looking at the medical field when they acquired Toyama chemical. In the following years, the company focused on acquiring more pharmaceutical and diagnosis companies. For the company’s CEO Shigetaka Komori, this is an opportunity to help Japan escape the COVID-19 pandemic.
Based on the results of clinical trials on 340 infected patients in Shenzhen and Wuhan, Fujifilm’s coronavirus drug Avigan has proved effective in reducing the duration of the coronavirus in patients as well as improving the lung conditions of patients that got treatment with this drug.
There was a reduction in the period in which a patient tested positive for COVID-19, decreasing from 11 days to 4 days. Besides, about 91 percent of the patients who received treatment with Avigan had improved lung conditions.
Japanese and Chinese experts considered Avigan a potential cure for COVID-19 though there’s no certainty as it still causes side effects. However, the company is not only working on a cure but also a new testing method for the coronavirus that can be implemented on a large scale.
>>> How To Kill Coronavirus: Effective Products To Sanitize Your Home
>>> US Begins Testing A COVID-19 Vaccine On Humans Today, Bringing Hope To Mankind
Featured Stories
Features - Jul 01, 2025
What Are The Fastest Passenger Vehicles Ever Created?
Features - Jun 25, 2025
Japan Hydrogen Breakthrough: Scientists Crack the Clean Energy Code with...
ICT News - Jun 25, 2025
AI Intimidation Tactics: CEOs Turn Flawed Technology Into Employee Fear Machine
Review - Jun 25, 2025
Windows 11 Problems: Is Microsoft's "Best" OS Actually Getting Worse?
Features - Jun 22, 2025
Telegram Founder Pavel Durov Plans to Split $14 Billion Fortune Among 106 Children
ICT News - Jun 22, 2025
Neuralink Telepathy Chip Enables Quadriplegic Rob Greiner to Control Games with...
Features - Jun 21, 2025
This Over $100 Bottle Has Nothing But Fresh Air Inside
Features - Jun 18, 2025
Best Mobile VPN Apps for Gaming 2025: Complete Guide
Features - Jun 18, 2025
A Math Formula Tells Us How Long Everything Will Live
Features - Jun 16, 2025